Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models

• Main Authors: Delphine Valente (Author), Christine Mauriac (Author), Thorsten Schmidt (Author), Ingo Focken (Author), Jochen Beninga (Author), Brian Mackness (Author), Huawei Qiu (Author), Pascale Vicat (Author), Abdullah Kandira (Author), Katarina Radošević (Author), Srini Rao (Author), John Darbyshire (Author), Mostafa Kabiri (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Monoclonal antibodies (mAbs) are among the fastest growing and most effective therapies for myriad diseases. Multispecific antibodies are an emerging class of novel therapeutics that can target more than one tumor- or immune-associated modulators per molecule. The combination of different binding af...